ChemoCentryx (CCXI) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts CCXI Hot Sheet
Join SI Premium – FREE
ChemoCentryx (NASDAQ: CCXI) reported Q1 EPS of ($0.28), in-line with the analyst estimate of ($0.28).
For earnings history and earnings-related data on ChemoCentryx (CCXI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bank of America (BAC) Tops Q1 EPS by $0.07, Beats on Revenue
- Johnson & Johnson (JNJ) Tops Q1 EPS by 7c, Revenue Slightly Misses
- Scilex (SCLX) Provides Preliminary Financial Results For Gross and Net Sales for ZTlido® for the First Quarter 2024
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
